PineBridge Investments’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32M Sell
266,126
-71,357
-21% -$8.24M 0.27% 76
2025
Q4
$35.5M Sell
337,483
-95,044
-22% -$8.92M 0.26% 76
2025
Q3
$36.3M Sell
432,527
-41,514
-9% -$3.42M 0.27% 83
2025
Q2
$37.5M Buy
474,041
+140,245
+42% +$11.1M 0.3% 81
2025
Q1
$30M Sell
333,796
-62,957
-16% -$5.88M 0.24% 92
2024
Q4
$39.5M Sell
396,753
-194,480
-33% -$20M 0.3% 71
2024
Q3
$67.1M Buy
591,233
+27,240
+5% +$3.24M 0.5% 36
2024
Q2
$69.9M Sell
563,993
-116,023
-17% -$14.9M 0.56% 28
2024
Q1
$89.7M Sell
680,016
-105,684
-13% -$13M 0.71% 20
2023
Q4
$85.7M Buy
785,700
+452,104
+136% +$46.9M 0.79% 20
2023
Q3
$34.3M Sell
333,596
-122,138
-27% -$13.2M 0.38% 64
2023
Q2
$52.6M Buy
455,734
+206,499
+83% +$23.4M 0.57% 32
2023
Q1
$26.5M Sell
249,235
-80,545
-24% -$8.7M 0.3% 87
2022
Q4
$36.6M Sell
329,780
-31,649
-9% -$3.24M 0.44% 53
2022
Q3
$31.1M Buy
361,429
+41,439
+13% +$3.7M 0.4% 56
2022
Q2
$29.2M Sell
319,990
-7,381
-2% -$654K 0.37% 59
2022
Q1
$26.9M Sell
327,371
-108,445
-25% -$8.55M 0.29% 85
2021
Q4
$33.4M Buy
435,816
+333,707
+327% +$26.6M 0.34% 58
2021
Q3
$7.67M Sell
102,109
-56,318
-36% -$4.28M 0.09% 215
2021
Q2
$12.3M Sell
158,427
-132,470
-46% -$9.85M 0.14% 173
2021
Q1
$21.4M Buy
290,897
+145,548
+100% +$10.7M 0.27% 87
2020
Q4
$11.3M Sell
145,349
-176,967
-55% -$13.5M 0.17% 147
2020
Q3
$25.5M Sell
322,316
-48,287
-13% -$3.78M 0.44% 48
2020
Q2
$27.3M Sell
370,603
-349,984
-49% -$26.3M 0.52% 42
2020
Q1
$52.9M Buy
720,587
+63,992
+10% +$5.03M 1.24% 10
2019
Q4
$57M Buy
656,595
+10,884
+2% +$894K 0.88% 19
2019
Q3
$51.9M Buy
645,711
+33,546
+5% +$2.69M 0.84% 16
2019
Q2
$49M Buy
612,165
+241,435
+65% +$18.5M 0.8% 24
2019
Q1
$29.4M Buy
370,730
+203,029
+121% +$15.2M 0.6% 41
2018
Q4
$12.2M Buy
167,701
+105,578
+170% +$7.45M 0.27% 105
2018
Q3
$4.21M Buy
62,123
+21,280
+52% +$1.36M 0.08% 218
2018
Q2
$2.37M Sell
40,843
-200,968
-83% -$11.3M 0.06% 317
2018
Q1
$12.6M Sell
241,811
-312,708
-56% -$16.9M 0.3% 95
2017
Q4
$29.8M Sell
554,519
-17,536
-3% -$972K 0.77% 20
2017
Q3
$35M Buy
572,055
+47,529
+9% +$2.88M 0.84% 17
2017
Q2
$32.1M Buy
524,526
+57,658
+12% +$3.51M 0.84% 21
2017
Q1
$28.3M Sell
466,868
-7,043
-1% -$427K 0.74% 23
2016
Q4
$26.6M Buy
473,911
+35,885
+8% +$2.1M 0.79% 22
2016
Q3
$26.1M Buy
438,026
+35,420
+9% +$2.07M 1.16% 13
2016
Q2
$22.1M Buy
402,606
+98,513
+32% +$5.24M 1.14% 12
2016
Q1
$15.4M Buy
304,093
+185,343
+156% +$9.08M 0.79% 31
2015
Q4
$5.99M Buy
118,750
+2,952
+3% +$149K 0.26% 108
2015
Q3
$5.46M Buy
115,798
+61,011
+111% +$3.24M 0.23% 121
2015
Q2
$2.98M Buy
54,787
+31,149
+132% +$1.75M 0.12% 158
2015
Q1
$1.3M Sell
23,638
-490,187
-95% -$27.8M 0.05% 238
2014
Q4
$27.8M Buy
513,825
+444,065
+637% +$24.7M 1.05% 16
2014
Q3
$3.95M Buy
69,760
+24,896
+55% +$1.4M 0.16% 150
2014
Q2
$2.48M Buy
44,864
+2,202
+5% +$120K 0.1% 203
2014
Q1
$2.31M Sell
42,662
-46,419
-52% -$2.4M 0.08% 210
2013
Q4
$4.25M Sell
89,081
-30,409
-25% -$1.39M 0.13% 163
2013
Q3
$5.43M Buy
119,490
+55
+0% +$2.51K 0.17% 150
2013
Q2
$5.29M Buy
+119,435
New +$5.33M 0.17% 153

Other funds holding MRK

PineBridge Investments's MRK Position: Q1 2026 in Review

PineBridge Investments reduced its Merck (MRK) stake by 21% in Q1 2026, selling an estimated $8.24M and leaving 266,126 shares worth $32M. The position accounts for 0.27% of the portfolio, ranked #76.

PineBridge Investments first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $89.7M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • PineBridge Investments held 266,126 shares of Merck worth $32M as of Q1 2026.
  • PineBridge Investments sold 71,357 Merck shares in Q1 2026, an estimated $8.24M.
  • Merck made up 0.27% of PineBridge Investments's portfolio in Q1 2026, its #76 holding.
  • PineBridge Investments first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
  • PineBridge Investments's Merck position peaked at $89.7M in Q1 2024.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on PineBridge Investments's 13F filing for Q1 2026, filed 14 May 2026.